larotrectinib
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
3 FDA-registered drug labelers
Bayer HealthCare Pharmaceuticals Inc.
Loxo Oncology, Inc.
Penn Pharmaceutical Services Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Vitrakvi
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1223403-58-4
PubChem CID46188928
DTXSIDDTXSID101020707
FormulaC21H22F2N6O2
Mol. Weight428.4 g/mol
SMILESC1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F
Data Sources
461889282026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/larotrectinib/cids/JSON
Archive: data/sources/pubchem_name/larotrectinib.json
CAS 1223403-58-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json